Drug residue formation from ronidazole, a 5-nitroimidazole. VI. Lack of mutagenic activity of reduced metabolites and derivatives of ronidazole. 1984

P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu

The potential toxicity of ronidazole residues present in the tissues of food-producing animals was assessed using the Ames mutagenicity test. Since ronidazole is activated by reduction, reduced derivatives of ronidazole and metabolites formed by enzymatic reduction of ronidazole were tested for mutagenicity. When tested at levels several orders of magnitude higher than that at which ronidazole was mutagenic, 5-amino-4-S-cysteinyl-1,2- dimethylimidazole , a product of the dithionite reduction of ronidazole in the presence of cysteine, the 5-N-acetylamino derivative of ronidazole and 5-amino-1,2- dimethylimidazole all lacked mutagenic activity in Ames strain TA100. The metabolites of ronidazole formed by the incubation of ronidazole with microsomes under anaerobic conditions were also not mutagenic. These data demonstrate that although ronidazole is a potent mutagen, residues from it which may be present in the tissues of food-producing animals lack any mutagenic activity.

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012385 Ronidazole Antiprotozoal and antimicrobial agent used mainly in veterinary practice. Ridzol,Ronida,Ronidazol
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu
September 1982, Chemico-biological interactions,
P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu
September 1982, Chemico-biological interactions,
P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu
July 1984, Chemico-biological interactions,
P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu
March 1992, Chemico-biological interactions,
P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu
September 1982, Chemico-biological interactions,
P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu
July 1983, Chemico-biological interactions,
P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu
February 1971, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu
November 1989, Farmaco (Societa chimica italiana : 1989),
P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu
June 1993, Journal of chemotherapy (Florence, Italy),
P G Wislocki, and E S Bagan, and M M Cook, and M O Bradley, and F J Wolf, and A Y Lu
October 1993, The new microbiologica,
Copied contents to your clipboard!